|
||||||
|
 | |
| |
| |
| |
| |
|
Fusion gene ID: 7196 |
FusionGeneSummary for CHST8_PDCD5 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: CHST8_PDCD5 | Fusion gene ID: 7196 | Hgene | Tgene | Gene symbol | CHST8 | PDCD5 | Gene ID | 64377 | 9141 |
| Gene name | carbohydrate sulfotransferase 8 | programmed cell death 5 | |
| Synonyms | GALNAC4ST1|GalNAc4ST|PSS3 | TFAR19 | |
| Cytomap | 19q13.11 | 19q13.11 | |
| Type of gene | protein-coding | protein-coding | |
| Description | carbohydrate sulfotransferase 8GALNAC-4-ST1GalNAc-4-O-sulfotransferase 1N-acetylgalactosamine-4-O-sulfotransferase 1carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 8galNAc4ST-1 | programmed cell death protein 5TF-1 cell apoptosis-related protein 19TF1 cell apoptosis-related gene 19TFAR19 novel apoptosis-related | |
| Modification date | 20180519 | 20180523 | |
| UniProtAcc | Q9H2A9 | O14737 | |
| Ensembl transtripts involved in fusion gene | ENST00000434302, ENST00000438847, ENST00000604556, ENST00000262622, | ENST00000590247, ENST00000419343, ENST00000592786, ENST00000379316, ENST00000586035, | |
| Fusion gene scores | * DoF score | 4 X 2 X 4=32 | 3 X 1 X 3=9 |
| # samples | 4 | 3 | |
| ** MAII score | log2(4/32*10)=0.321928094887362 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(3/9*10)=1.73696559416621 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | |
| Context | PubMed: CHST8 [Title/Abstract] AND PDCD5 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Functional or gene categories assigned by FusionGDB annotation | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | CHST8 | GO:0006790 | sulfur compound metabolic process | 11445554 |
| Hgene | CHST8 | GO:0030166 | proteoglycan biosynthetic process | 10988300 |
| Tgene | PDCD5 | GO:0010628 | positive regulation of gene expression | 24012345 |
| Tgene | PDCD5 | GO:0071560 | cellular response to transforming growth factor beta stimulus | 24012345 |
| Fusion gene information from three resources (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| TCGA | RV | PRAD | TCGA-EJ-A46G-01A | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| * LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5UTR-3CDS | ENST00000434302 | ENST00000590247 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000434302 | ENST00000419343 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000434302 | ENST00000592786 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000434302 | ENST00000379316 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-5UTR | ENST00000434302 | ENST00000586035 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000438847 | ENST00000590247 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000438847 | ENST00000419343 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000438847 | ENST00000592786 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-3CDS | ENST00000438847 | ENST00000379316 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 5UTR-5UTR | ENST00000438847 | ENST00000586035 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 3UTR-3CDS | ENST00000604556 | ENST00000590247 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 3UTR-3CDS | ENST00000604556 | ENST00000419343 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 3UTR-3CDS | ENST00000604556 | ENST00000592786 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 3UTR-3CDS | ENST00000604556 | ENST00000379316 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| 3UTR-5UTR | ENST00000604556 | ENST00000586035 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| intron-3CDS | ENST00000262622 | ENST00000590247 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| intron-3CDS | ENST00000262622 | ENST00000419343 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| intron-3CDS | ENST00000262622 | ENST00000592786 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| intron-3CDS | ENST00000262622 | ENST00000379316 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
| intron-5UTR | ENST00000262622 | ENST00000586035 | CHST8 | chr19 | 34113202 | + | PDCD5 | chr19 | 33073101 | + |
Top |
FusionProtFeatures for CHST8_PDCD5 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| CHST8 | PDCD5 |
| Catalyzes the transfer of sulfate to position 4 of non-reducing N-acetylgalactosamine (GalNAc) residues in both N-glycansand O-glycans. Required for biosynthesis of glycoprotein hormoneslutropin and thyrotropin, by mediating sulfation of theircarbohydrate structures. Only active against terminalGalNAcbeta1,GalNAcbeta. Not active toward chondroitin.{ECO:0000269|PubMed:10988300, ECO:0000269|PubMed:11445554}. | May function in the process of apoptosis. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at . * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for CHST8_PDCD5 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. (nt: nucleotides, aa: amino acids) |
| * Fusion amino acid sequences. |
| * Fusion transcript sequences (only coding sequence (CDS) region). |
| * Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for CHST8_PDCD5 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in . |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| CHST8 | TMED1, CANX, FREM2, C1QBP, FRAS1, TMEM160, P3H4, RBM27, TOR3A, RBM23, CLSTN1, YBEY, ARL10, SEPN1, TMED9, TMED4, TXNDC11, MOXD1, JMJD4, GALNT12, SEC62, GPC6, TMED2, FBL, CHCHD2, MRS2, EDEM2, RRP1, B3GALNT2, GAL3ST1, NOP9, FAM3C, FSTL1 | PDCD5 | ACP5, KAT5, KIAA1377, LRIF1, UTP14A, EEF1G, TCEAL1, NUDT3, UBE2D3, FBXW8, TP53, MDM2, FN1, METTL21B, LMNA, KDM1A, VHL, TUBG1, OTUD5, STMN1, CETN2, YAF2, ARRDC5, ATP1B1 |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for CHST8_PDCD5 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.0 2018-04-02) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for CHST8_PDCD5 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
| Hgene | CHST8 | C4015729 | PEELING SKIN SYNDROME 3 | 1 | ORPHANET;UNIPROT |
Copyright 2018-Present -The University of Texas Health Science Center at Houston (UTHealth)
|